Kiyosumi Ochi, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chimera | 1 | 2021 | 484 | 0.710 |
Why?
|
| Splenic Neoplasms | 1 | 2017 | 100 | 0.560 |
Why?
|
| Antilymphocyte Serum | 1 | 2018 | 492 | 0.550 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2021 | 3389 | 0.520 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2017 | 180 | 0.520 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2017 | 142 | 0.510 |
Why?
|
| Hemoglobin Subunits | 1 | 2014 | 1 | 0.500 |
Why?
|
| beta-Globins | 1 | 2014 | 115 | 0.460 |
Why?
|
| Erythropoiesis | 2 | 2014 | 706 | 0.450 |
Why?
|
| Bone Marrow Transplantation | 1 | 2021 | 2764 | 0.440 |
Why?
|
| Bone Marrow | 1 | 2021 | 2951 | 0.380 |
Why?
|
| Pluripotent Stem Cells | 2 | 2014 | 795 | 0.310 |
Why?
|
| Flow Cytometry | 2 | 2014 | 5973 | 0.240 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 3524 | 0.210 |
Why?
|
| Transplantation Chimera | 1 | 2021 | 613 | 0.160 |
Why?
|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2018 | 31 | 0.160 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2018 | 166 | 0.150 |
Why?
|
| Gene Transfer Techniques | 1 | 2021 | 1224 | 0.130 |
Why?
|
| bcl-X Protein | 2 | 2014 | 411 | 0.130 |
Why?
|
| Genetic Engineering | 1 | 2021 | 950 | 0.130 |
Why?
|
| Splenectomy | 1 | 2017 | 394 | 0.130 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2017 | 272 | 0.130 |
Why?
|
| gamma-Globins | 1 | 2014 | 95 | 0.120 |
Why?
|
| GTP Phosphohydrolases | 1 | 2017 | 508 | 0.110 |
Why?
|
| Erythroblasts | 1 | 2013 | 150 | 0.110 |
Why?
|
| Bone Marrow Cells | 1 | 2021 | 2509 | 0.110 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 689 | 0.110 |
Why?
|
| Genes, myc | 1 | 2013 | 399 | 0.110 |
Why?
|
| Molecular Probes | 1 | 2014 | 315 | 0.110 |
Why?
|
| Antigens, CD34 | 1 | 2014 | 658 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5445 | 0.100 |
Why?
|
| Hematopoiesis | 1 | 2021 | 2073 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2014 | 988 | 0.100 |
Why?
|
| Transplantation Conditioning | 1 | 2018 | 1599 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2014 | 1342 | 0.090 |
Why?
|
| Transplantation, Homologous | 1 | 2018 | 4777 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2503 | 0.090 |
Why?
|
| Megakaryocytes | 1 | 2014 | 545 | 0.090 |
Why?
|
| Embryonic Stem Cells | 2 | 2014 | 1295 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 1691 | 0.090 |
Why?
|
| Cell Differentiation | 3 | 2014 | 11478 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2014 | 1537 | 0.080 |
Why?
|
| Transfection | 1 | 2014 | 5892 | 0.070 |
Why?
|
| Thrombocytopenia | 1 | 2014 | 1178 | 0.070 |
Why?
|
| Survival Rate | 1 | 2018 | 12786 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 21824 | 0.060 |
Why?
|
| Blood Platelets | 1 | 2014 | 2509 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2014 | 3024 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 3622 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 1733 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2014 | 5021 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2017 | 7880 | 0.040 |
Why?
|
| Mice, Inbred NOD | 2 | 2014 | 1876 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 5854 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2017 | 5185 | 0.040 |
Why?
|
| Mice, SCID | 2 | 2014 | 2718 | 0.040 |
Why?
|
| Middle Aged | 5 | 2018 | 213241 | 0.040 |
Why?
|
| Blast Crisis | 1 | 2017 | 103 | 0.040 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2017 | 104 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11524 | 0.040 |
Why?
|
| Mice | 2 | 2021 | 81154 | 0.030 |
Why?
|
| Pyridazines | 1 | 2017 | 202 | 0.030 |
Why?
|
| Recurrence | 2 | 2017 | 8337 | 0.030 |
Why?
|
| Drug Substitution | 1 | 2017 | 281 | 0.030 |
Why?
|
| Male | 4 | 2021 | 349776 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2013 | 203 | 0.030 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2013 | 147 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 1851 | 0.030 |
Why?
|
| Animals | 3 | 2021 | 168660 | 0.030 |
Why?
|
| Humans | 8 | 2018 | 743811 | 0.030 |
Why?
|
| GATA1 Transcription Factor | 1 | 2013 | 293 | 0.030 |
Why?
|
| Time Factors | 1 | 2014 | 40038 | 0.030 |
Why?
|
| Mutation | 1 | 2017 | 29777 | 0.030 |
Why?
|
| Female | 4 | 2018 | 380020 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2017 | 2123 | 0.030 |
Why?
|
| Cell Size | 1 | 2013 | 641 | 0.030 |
Why?
|
| Imidazoles | 1 | 2017 | 1206 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2013 | 913 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 63042 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 4931 | 0.020 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2017 | 895 | 0.020 |
Why?
|
| Aged | 2 | 2018 | 163178 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2013 | 1531 | 0.020 |
Why?
|
| Adult | 2 | 2018 | 213889 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 1677 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2017 | 2945 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2018 | 9139 | 0.010 |
Why?
|
| Oxygen | 1 | 2013 | 4189 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2014 | 19232 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 12066 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 18027 | 0.010 |
Why?
|